What Nutrients Should GLP-1 Users Prioritize
266 placebo) were categorized into 3 groups based on LVEF: 45% to 49% (n = 85), 50% to 59% (n = 215), and 60% (n = 229) (Table 1)
Pune 169 cm 33-26-35 24 years Influencer 152 views Unnati Malharkar Unnati Malharkar is a professional dancer, choreographer, and digital creator
Limitations 1 : 1 : Results should be interpreted with caution because of the retrospective pre-post design without a control or comparator arm and the relatively short follow-up (6 months) Hypoglycemia may have been underreported, as only the clinically significant events were likely to have been captured (eg, no SMBG or CGM data) EMR database analysis as a potential for selection bias that cannot be controlled, as well as EMR data-capture challenges (eg, coding errors, no dosing data) Patients were mainly from the Northwest and Southern US states and therefore may not be representative of the US national landscape Sanofi-sponsored study *Follow-up period 6 months included GLP-1 RA + Toujeo (N=271)
Impact on providers like Priority Meds Priority Meds has not made public statements, as far as publicly available information shows, about how these regulatory changes affect their tirzepatide offerings